Vimarsana
Biggest News Aggregation in the World

Akouos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Akouos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Akouos Today - Breaking & Trending Today

Eli Lilly Sounds Off as Early Data Show How Gene Therapy Can Restore Hearing - Vimarsana News

Eli Lilly Sounds Off as Early Data Show How Gene Therapy Can Restore Hearing

Eli Lilly said its experimental gene therapy restored hearing in a boy born with profound hearing loss. The results for this experimental treatment come three months after Regeneron Pharmaceuticals reported early but encouraging data for its hearing loss gene therapy.

Gene Therapy Allows an 11-Year-Old Boy to Hear for the First Time - Vimarsana News

Gene Therapy Allows an 11-Year-Old Boy to Hear for the First Time

The genetic treatment targeted a particular kind of congenital deafness and will soon be tried in children who are younger.

Eli Lilly to buy gene therapy company Akouos for $487 million - Vimarsana News

Eli Lilly to buy gene therapy company Akouos for $487 million

Eli Lilly to buy gene therapy company Akouos for $487 million

Eli Lilly To Buy Akouos For Up To $610 Mln - Vimarsana News

Eli Lilly To Buy Akouos For Up To $610 Mln

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) Tuesday announced its decision to acquire Akouos, Inc. (AKUS), a developer of viral gene therapies for the treatment of inner ear conditions

Eli Lilly's $487M Akouos buyout expands its gene therapy scope to hearing loss - Vimarsana News

Eli Lilly's $487M Akouos buyout expands its gene therapy scope to hearing loss

Eli Lilly is acquiring Akouos on the heels of the biotech receiving FDA permission to begin a clinical trial testing its gene therapy for an inherited form of hearing loss. The deal is Lilly’s second gene therapy acquisition following the 2021 buyout of Prevail Therapeutics.